Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
Apyx Medical Corporation (APYX)
Last apyx medical corporation earnings: 3/16 04:27 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
The number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same period last yearSubmitted a 510(k) premarket notification to the U.S. FDA for the AYON™ Body Contouring System ahead of schedule and preparing for a planned launch in the back half of 2025, pending clearanceManagement to host a conference call today at 8:30 a.m. ET CLEARWATER, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today reported the financial results for its fourth quarter and year ended December 31, 2024. Recent Financial and Operating Highlights: Reported total revenue of $14.2 million in the fourth quarter of 2024, driven by positive momentum in U.S. capital equipment and single-use handpiece sales growth
Show less
Read more
Impact Snapshot
Event Time:
APYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APYX alerts
High impacting Apyx Medical Corporation news events
Weekly update
A roundup of the hottest topics
APYX
News
- Apyx Medical (NASDAQ:APYX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.MarketBeat
- Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South KoreaGlobeNewswire
- Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common StockGlobeNewswire
- Apyx Medical Corporation Announces Proposed Public Offering of Common Stock [Yahoo! Finance]Yahoo! Finance
- Apyx Medical announces public offering of common stock; shares down [Seeking Alpha]Seeking Alpha
APYX
Earnings
- 3/13/25 - Beat
APYX
Sec Filings
- 12/12/25 - Form 8-K
- 12/1/25 - Form S-3
- 11/19/25 - Form 8-K
- APYX's page on the SEC website